Maya Azrad

614 total citations
48 papers, 422 citations indexed

About

Maya Azrad is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Maya Azrad has authored 48 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 13 papers in Epidemiology and 10 papers in Molecular Medicine. Recurrent topics in Maya Azrad's work include Clostridium difficile and Clostridium perfringens research (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Maya Azrad is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Maya Azrad collaborates with scholars based in Israel and Germany. Maya Azrad's co-authors include Avi Peretz, Moshe Gavish, Leo Veenman, Orna Nitzan, Arnon Blum, Avi On, Abraham Weizman, Julia Bode, Beatriz Caballero and Sukhdev Singh and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Microbiology and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Maya Azrad

43 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maya Azrad Israel 11 127 117 73 53 40 48 422
Matthew Stephens Canada 13 230 1.8× 71 0.6× 113 1.5× 81 1.5× 44 1.1× 33 616
Shinobu Kobayashi Japan 15 212 1.7× 114 1.0× 113 1.5× 49 0.9× 15 0.4× 38 688
Lia Monica Junie Romania 13 96 0.8× 108 0.9× 73 1.0× 41 0.8× 17 0.4× 42 387
Qian Huang China 11 192 1.5× 132 1.1× 39 0.5× 29 0.5× 15 0.4× 29 441
Qingyu Lv China 15 205 1.6× 65 0.6× 99 1.4× 18 0.3× 19 0.5× 47 501
Deborah De Geyter Belgium 13 105 0.8× 137 1.2× 123 1.7× 13 0.2× 98 2.5× 36 502
Stefano Léo Switzerland 15 376 3.0× 152 1.3× 157 2.2× 44 0.8× 63 1.6× 28 754
Ahmed M. Al‐Hakami Saudi Arabia 12 61 0.5× 53 0.5× 105 1.4× 41 0.8× 35 0.9× 32 345
Yun Xia China 17 271 2.1× 128 1.1× 131 1.8× 50 0.9× 107 2.7× 42 751
Rong Mu United States 14 216 1.7× 51 0.4× 170 2.3× 25 0.5× 10 0.3× 31 665

Countries citing papers authored by Maya Azrad

Since Specialization
Citations

This map shows the geographic impact of Maya Azrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Azrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Azrad more than expected).

Fields of papers citing papers by Maya Azrad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya Azrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Azrad. The network helps show where Maya Azrad may publish in the future.

Co-authorship network of co-authors of Maya Azrad

This figure shows the co-authorship network connecting the top 25 collaborators of Maya Azrad. A scholar is included among the top collaborators of Maya Azrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya Azrad. Maya Azrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Azrad, Maya, et al.. (2024). The effect of three urease inhibitors on H. pylori viability, urease activity and urease gene expression. Frontiers in Microbiology. 15. 1464484–1464484. 8 indexed citations
3.
Ken‐Dror, Shifra, et al.. (2024). Diagnosing gastrointestinal infections based on cycle threshold cut-offs of PCR. Microbiology Spectrum. 13(2). e0123424–e0123424. 1 indexed citations
4.
Azrad, Maya, et al.. (2024). Associations between biofilm formation and virulence factors among clinical Helicobacter pylori isolates. Microbial Pathogenesis. 196. 106977–106977. 1 indexed citations
5.
Ben-Amram, Hila, et al.. (2024). Biofilm Formation by Hospital-Acquired Resistant Bacteria Isolated from Respiratory Samples. Journal of Epidemiology and Global Health. 14(2). 291–297. 5 indexed citations
7.
Azrad, Maya, et al.. (2023). Trend of Changes in Chloramphenicol Resistance during the Years 2017–2020: A Retrospective Report from Israel. Antibiotics. 12(2). 196–196. 6 indexed citations
8.
Azrad, Maya, et al.. (2023). Associations of motility and auto-aggregation with biofilm-formation capacity levels in Clostridioides difficile. Microbial Pathogenesis. 186. 106490–106490. 3 indexed citations
9.
Azrad, Maya, et al.. (2023). The Impact of a Positive Biofire® FilmArray® Gastrointestinal Panel Result on Clinical Management and Outcomes. Diagnostics. 13(6). 1094–1094. 4 indexed citations
10.
Azrad, Maya, et al.. (2022). Assessing the impact of a positive Biofire® FilmArray® Meningitis/Encephalitis Panel result on clinical management and outcomes. Diagnostic Microbiology and Infectious Disease. 104(3). 115769–115769.
12.
Nitzan, Orna, et al.. (2021). Tinea capitis in an immigrant pediatric community; a clinical signs-based treatment approach. BMC Pediatrics. 21(1). 363–363. 8 indexed citations
13.
Azrad, Maya, et al.. (2021). Reduced Susceptibility to Chlorhexidine among Staphylococcus aureus Isolates in Israel: Phenotypic and Genotypic Tolerance. Antibiotics. 10(3). 342–342. 6 indexed citations
14.
Peretz, Avi, et al.. (2020). Performance of the Influ a + B K-SeT® assay as compared to two RT-PCR assays for detection of influenza virus. Diagnostic Microbiology and Infectious Disease. 98(1). 115097–115097. 1 indexed citations
15.
Nagler, Rafael M., et al.. (2020). 18-kDa Translocator Protein Ligands Protect H9C2 Cardiomyocytes from Cigarette Smoke-induced Cell Death: In Vitro Study. In Vivo. 34(2). 549–556. 2 indexed citations
16.
Peretz, Avi, et al.. (2020). Mycoplasma and Ureaplasma carriage in pregnant women: the prevalence of transmission from mother to newborn. BMC Pregnancy and Childbirth. 20(1). 456–456. 15 indexed citations
17.
Azrad, Maya, et al.. (2019). Detection of group a Streptococcus in pharyngitis by two rapid tests: comparison of the BD Veritor™ and the QuikRead go® Strep A. European Journal of Clinical Microbiology & Infectious Diseases. 38(6). 1179–1185. 4 indexed citations
18.
Binyamin, Dana, et al.. (2018). In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile. Frontiers in Microbiology. 9. 1256–1256. 5 indexed citations
19.
Azrad, Maya, et al.. (2018). Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli: comparison between Etest and a broth dilution method. Annals of Clinical Microbiology and Antimicrobials. 17(1). 23–23. 25 indexed citations
20.
On, Avi, et al.. (2018). Characteristics of Antibiotic Resistance of Helicobacter pylori Among Adult Arab and Jewish Populations in Northern Israel. Microbial Drug Resistance. 25(1). 103–107. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026